Comparative study of alterations in Tri-iodothyronine (T3) and Thyroxine (T4) hormone levels in breast and ovarian cancer

Abstract

Objective: The present study was designed to investigate variations in the levels of thyroid hormones (T3, T4) in breast and ovarian cancers patients.

Methods: A total 120 subjects were recruited (without thyroid history) divided into three groups; A, B and C. Group A as control with healthy individuals. While group B and group C were consisting of breast cancer and ovarian cancer patient respectively. Blood samples (5 ml) were taken and analyzed to estimate the levels of serum T3 (tri-iodothyronine) and T4 (thyroxin) hormones.

Results: Statistically significant difference (P=0.000* and P=0.017*) was obtained among all groups. A significant increase in T3 (P=0.000*) and T4 (0.005*) levels was observed among breast cancer patients as compared to healthy controls. While for ovarian cancer patients conflicting results were found for T3 and T4 levels in the serum i.e. insignificant difference was found in T3 (P=0.209) and T4 (P=0.050) as compared to control. Our results showed that in the breast cancer and ovarian cancer patients the thyroid hormone (T3 and T4) level has been altered from the normal ranges as compared to the normal healthy individuals.

Conclusion: We conclude that hyperthyroidism has profound effects on breast cancer and ovarian cancer cells proliferation.

doi: http://dx.doi.org/10.12669/pjms.306.5294

How to cite this:Rasool M, Naseer MI, Zaigham K, Malik A, Riaz N, Alam R, et al. Comparative study of alterations in Tri-iodothyronine (T3) and Thyroxine (T4) hormone levels in breast and ovarian cancer. Pak J Med Sci 2014;30(6):1356-1360.   doi: http://dx.doi.org/10.12669/pjms.306.5294

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.